Knowledge about the HIV lifecycle and how HIV affects the body. News and research in basic science that may contribute to the development of new treatments, a cure or a vaccine.

How HIV works: latest news

How HIV works resources

How HIV works features

How HIV works in your own words

  • Seroconversion

    I was given my diagnosis over the telephone after spending four days in hospital with meningitis. I now realise it wasn’t meningitis, it was an...

    From: In your own words

How HIV works news from aidsmap

More news

How HIV works news selected from other sources

  • Insufficient food linked to inflammation in HIV-positive women

    Past research with HIV-negative people suggests that food insecurity is associated with heightened levels of inflammation. Now, in a recent study, scientists at 10 major clinics across the U.S. have found that food insecurity was linked to an increased risk of elevated inflammation among HIV-positive women. The link between food insecurity and inflammation was present even in women whose viral loads were suppressed due to good adherence to ART.

    29 January 2019 | CATIE
  • HIV Establishes Reservoir Within Three Days in Monkeys

    Beginning six months of treatment within two days following infection prevented viral rebound in at least some animals in a recent study.

    01 January 2019 | Poz
  • Study Determines Why Patients With HIV Have Higher Rates of Cancer

    After investigating why patients with HIV have higher rates of cancer than the general population, researchers identified how T-cells move and multiply to invade other cells in these patients.

    17 December 2018 | American Journal of Managed Care
  • Needles in a haystack: the quest for bnAbs

    HIV induces antibody responses in infected individuals, but only a few of these individuals manage to produce antibodies that are capable of viral neutralization—and even fewer produce antibodies that can neutralize different strains of HIV.

    01 December 2018 | Nature
  • Virus detectives test whole-body scans in search of HIV’s hiding places

    To prevent the virus from rebounding after drug therapy, researchers must first map where it lurks in the body.

    23 October 2018 | Nature
  • PET Scans May Predict Who Gets Inflammatory Reaction to HIV Treatment Start

    The imaging method known as a PET scan may be able to predict who among those starting antiretroviral (ARV) treatment with an immune system highly damaged by HIV will develop HIV-associated immune reconstitution syndrome (IRIS).

    26 September 2018 | Poz
  • Video SNiP: PET Scan “Hot Spots” Help Visualize Inflammatory Complication of HIV

    Infectious-disease and radiology researchers from NIAID and the NIH Clinical Center are working together to visualize and predict HIV-associated immune reconstitution syndrome (IRIS) in a new way—with positron emission tomography (PET). The researchers describe their findings in a paper published this week in Clinical Infectious Diseases and in a new NIAID Video SNiP.

    14 September 2018 | National Institute of Allergy and Infectious Diseases
  • Why has HIV in Saskatchewan become more harmful for some people?

    Reports have suggested that HIV may be progressing more rapidly in Saskatchewan. Researchers analyzed the genetic sequences of HIV among people in the province. They discovered strains of HIV that have adapted to some people’s immune defences.

    22 August 2018 | CATIE
  • Mutated strains of HIV in Saskatchewan causing illness quicker: study

    Research suggests mutated strains of HIV circulating in Saskatchewan are leading to faster-developing AIDS-related illnesses among Indigenous people.

    27 July 2018 | Calgary Herald
  • ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

    For virologically suppressed patients infected with HIV, switching to a dual antiretroviral maintenance therapy of atazanavir/ritonavir plus lamivudine does not affect plasma markers of systemic inflammation, according to results published in the Journal of Antimicrobial Chemotherapy.

    15 June 2018 | Infectious Disease Advisor
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.